232 results on '"Zurawski G"'
Search Results
2. P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
3. P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
4. Interleukin 13, a T-Cell-Derived Cytokine that Regulates Human Monocyte and B-Cell Function
5. TLR9- and CD40-Targeting Vaccination Promotes Human B Cell Maturation and IgG Induction via pDC-Dependent Mechanisms in Humanized Mice
6. Abstract P3-05-01: Immune and transcriptional signatures of dendritic dell (DC) vaccination combined with chemotherapy in locally advanced, triple-negative breast cancer (TNBC) patients
7. Organization and Structure of the Genes for the β and ε Subunits of Spinach and Pea Chloroplast ATPase
8. Structure of the Gene (tmpA) for the '32,000-Mr' Thylakoid Membrane Polypeptide of Spinacia Oleracea and Nicotiana Debneyi
9. The Synthesis, Processing and Primary Structure of Pea Seed Lectin
10. Immunoregulatory Properties of IL-13: Its Potential Role in Atopic Disease
11. CD34-derived dendritic cells transfected ex vivo with HIV-Gag mRNA induce polyfunctional T-cell responses in nonhuman primates
12. Brucella beta 1,2 cyclic glucan is an activator of human and mouse dendritic cells
13. The Expression and Characterization of Recombinant Mouse IL-3
14. Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates
15. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells
16. P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
17. P18-08. Characterization of CD34+ derived dendritic cells generated in vitro and transfected with HIV gene as potential therapeutic vaccine in macaque
18. S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
19. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes : comparison with IL-4 and modulation by Ifn-gamma or IL-10
20. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
21. CD38-mediated ribosylation of proteins.
22. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist.
23. Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor.
24. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
25. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.
26. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction.
27. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.
28. Receptor antagonist and selective agonist derivatives of mouse interleukin-2.
29. Receptor binding and internalization of mouse interleukin-2 derivatives that are partial agonists.
30. Identification of three adjacent amino acids of interleukin-2 receptor beta chain which control the affinity and the specificity of the interaction with interleukin-2.
31. Analysing lymphokine—receptor interactions of IL-1 and IL-2 by recombinant-DNA technology
32. Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction.
33. Identification of key residues in the amino-terminal third of human interleukin-1 alpha.
34. Evolution of Higher-Plant Chloroplast DNA-Encoded Genes: Implications for Structure-Function and Phylogenetic Studies.
35. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
36. A subpopulation of spinach chloroplast tRNA genes does not require upstream promoter elements for transcription.
37. Alterations in the amino-terminal third of mouse interleukin 2: effects on biological activity and immunoreactivity
38. Analysis of promoter regions for the spinach chloroplast rbcL, atpB and psbA genes.
39. Mouse interleukin‐2 structure‐function studies: substitutions in the first alpha‐helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha‐helix can specifically inactivate p55 receptor binding.
40. Identification of three critical regions within mouse interleukin 2 by fine structural deletion analysis.
41. Identification and mutational analysis of the promoter for a spinach chloroplast transfer RNA gene.
42. Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells.
43. Constraints on the evolution of plastid introns: the group II intron in the gene encoding tRNA-Val(UAC).
44. Amino-terminal sequence and processing of the precursor of the leucine-specific binding protein, and evidence for conformational differences between the precursor and the mature form.
45. The biosynthesis and primary structure of pea seed lectin.
46. Tumor necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced Stat6 activation.
47. Autocatalytic activation of human legumain at aspartic acid residues (FBS 21039)
48. Structural and functional analysis of cloned DNA containing genes responsible for branched-chain amino acid transport in Escherichia coli.
49. The nucleotide sequence preceding and including the beginning of the ilvE gene of the ilvGEDA operon of Escherichia coli K12.
50. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.